Sequence Bio
PrivateLast Round
VC Round
May 20, 2021
Est. Valuation
$2.14M
Total Funding Raised
$4.15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sequence Bio is a biotechnology company that leverages the unique genetics of the Newfoundland and Labrador founder population to discover drug targets and develop medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sequence Bio Comparables
Compare Sequence Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Population Bio, Inc. | 80% | |
| HiberCell | 77% | |
| Genomics | 76% |
Sequence Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 20, 2021 | ||||
| Accelerator | Aug 23, 2019 | ||||
| Seed | Aug 3, 2016 | ||||
| Seed | Oct 20, 2015 |
Key People
Founding team and executive leadership
Sequence Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Killick Capital | Seed |
| Y Combinator | Accelerator |
| Pelorus Venture Capital | Seed |
| Klister Credit Corp. | Seed, VC Round |
| Columbus Capital | VC Round |
| DCVC (Data Collective) | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 2316% MoM, from 89 to 2.2K.
- May 11, 2026
Monthly visitors increased 42% MoM.
Sequence Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sequence Bio's valuation, stock price, and market status.
Is Sequence Bio a public or private company?
Sequence Bio is a private company.
What is the current stock price of Sequence Bio?
Sequence Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Sequence Bio worth (valuation)?
Sequence Bio's valuation is estimated at $2.1M based on funding round data.
Can I buy Sequence Bio stock?
Sequence Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sequence Bio's last funding round?
Sequence Bio's most recent funding round was VC Round on August 23, 2019.
Who are the main investors in Sequence Bio?
Key investors in Sequence Bio include Y Combinator, Columbus Capital.
Will Sequence Bio IPO soon?
No public IPO plans have been announced for Sequence Bio.
How can I track Sequence Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sequence Bio's secondary market activity and sign up for updates.